Reducible siRNA dimeric conjugates for efficient cellular uptake and gene silencing
Hyun Jung Chung1, Cheol Am Hong, Soo Hyeon Lee
1Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 305-701, Republic of Korea.
Bioconjugate Chemistry
|January 13, 2011
Summary
Dimerized siRNAs, linked by a cleavable disulfide bond, show enhanced delivery and gene silencing. These novel dimeric small interfering RNAs (siRNAs) offer improved cellular uptake and therapeutic potential for gene therapy.
Area of Science:
- Biotechnology
- Molecular Biology
- Gene Therapy
Background:
- Monomeric small interfering RNA (siRNA) delivery faces challenges in cellular uptake and gene silencing efficiency.
- Developing advanced siRNA formulations is crucial for effective gene therapy applications.
Purpose of the Study:
- To synthesize and characterize dimerized siRNAs linked by a cleavable disulfide bond for enhanced intracellular delivery and gene silencing.
- To evaluate the complexation, cellular uptake, and gene silencing efficacy of dimerized siRNAs compared to monomeric siRNAs.
Main Methods:
- Synthesis of reducible dimerized siRNAs.
- Complexation studies with cationic polymers (linear polyethylenimine - LPEI) using microscopy and gel characterization.
- In vitro transfection of various cell lines with dimerized siRNA/LPEI complexes targeting green fluorescent protein (GFP) and vascular endothelial growth factor (VEGF).
- Characterization of PEG-modified dimerized siRNAs and heterodimers targeting multiple genes.
Main Results:
- Dimerized siRNAs exhibited superior complexation with cationic polymers compared to monomeric siRNAs at equivalent N/P ratios.
- Dimeric siRNA/LPEI complexes demonstrated significantly enhanced cellular uptake and gene silencing effects in vitro versus monomeric siRNA/LPEI complexes.
- The improved performance is attributed to the higher charge density and increased chain flexibility of dimerized siRNAs, leading to more compact and stable complexes.
- Successful synthesis and characterization of modified dimerized siRNAs, including PEGylated versions and heterodimers for multi-target gene silencing.
Conclusions:
- Reducible dimerized siRNA complexes represent a promising platform for efficient gene delivery and silencing.
- The enhanced properties of dimerized siRNAs facilitate improved cellular internalization and gene knockdown.
- This dimerized siRNA complex system holds significant potential for advancing in vivo systemic gene therapy applications.
Related Concept Videos
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
02:30Small interfering RNAs (siRNA)
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...